|
|
Meta-analysis of the relationship between MTHFR C677 gene polymorphism and coronary artery heart disease in Chinese population#br# |
LIU Chengming1 PANG Jun2▲ HU Wenyu3 TANG Anying3 WU Qiang2 HUANG Jing2 ZHOU Yu2 LIU Wei2 |
1.Department of Emergency, Guizhou Provincial People’s Hospital, Guizhou Province, Guiyang 730000, China;
2.Department of Cardiology, Guizhou Provincial People’s Hospital, Guizhou Province, Guiyang 730000, China;
3.Clinical Medical School, Guizhou Medical University, Guizhou Province, Guiyang 730000, China |
|
|
Abstract Objective To systematically evaluate the association between the incidence of coronary artery heart disease and the MTHFR C677 allele in China. Methods Case-control studies on the correlation between coronary artery heart disease and MTHFR C677 C/T gene were searched in English databases (PubMed, Embase, Cochrane Library) and Chinese databases (CNKI, VIP, Wanfang Data) from inception to February 2021. The quality of the included literatures was evaluated. Data were meta-analyzed using RevMan 5.0 software. Results A total of 2412 cases were included in eight studies, including 1501 cases in the coronary artery heart disease group and 911 cases in the normal group. Meta-analysis showed that the expression of MTHFR C677 CC allele in coronary artery heart disease group was lower than that in normal group (OR = 1.59, 95%CI: 1.17-2.15, P = 0.003). There was no significant difference in MTHFR C677 CT allele expression between coronary artery heart disease group and normal group (OR = 0.91, 95%CI: 0.76-1.09, P = 0.30). The expression of MTHFR C677 TT allele in coronary artery heart disease group was higher than that in normal group (OR = 0.64, 95%CI: 0.52-0.79, P < 0.000 01). Conclusion The expression of MTHFR C677T gene is related to the incidence of coronary artery heart disease in Chinese population, and the TT allele expression is higher in coronary artery heart disease population.
|
|
|
|
|
[1] Gariglio L,Riviere S,Morales A,et al. Comparison of homocysteinemia and MTHFR 677CT polymorphism with Framingham Coronary Heart Risk Score [J]. Arch Cardiol Mex,2014,84(2):71-78.
[2] Xu H,Yu Q,Zhou H,et al. Polymorphisms in the GCK gene increase the risk of clopidogrel resistance in stable coronary artery disease(SCAD)patients [J]. Hematology,2021, 26(1):447-452.
[3] Bowden J,Spiller W,Del Greco MF,et al. Improving the visualization,interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression [J]. Int J Epidemiol,2018,47(4):1264-1278.
[4] Guyatt Gordon H,Oxman Andrew D,et al. GRADE:grade of evidence quality and strength of recommendation consensus [J]. Chin J Evidence-Based Med,2009,9(1):8-11.
[5] 张贞,宁兴旺,匡敏,等.湖南地区冠心病患者MTHFRC677T基因多态性与血浆同型半胱氨酸及血脂水平关系的研究[J].国际检验医学杂志,2018,10(39):2492-2495.
[6] 陈斌.MTHFR C677T基因多态性与皖北地区冠心病的相关性研究[D].蚌埠:蚌埠医学院,2018.
[7] 王欣丽,陈亮.MTHFR C677T基因多态性与老年冠心病心衰的相关性研究[J].中国医药导报,2016,12(13):12-15.
[8] 赵艳梅,许为炎,陈坚,等.同型半胱氨酸及其代谢酶MTHFR C677T基因多态性与广西壮族自治区玉林地区汉族冠心病患者的相关性[J].中国药物与临床,2016, 16(10):1409-1412.
[9] 霍朝霞,伍亚红,陈建忠,等.MTHFR C677T多态性与消化系统癌症及冠心病易感性的关系[J].现代临床医学,2016,10(42):334-337.
[10] 闫瑞丽,张春雨,王利丽,等.蒙古族冠心病人群与MTHFR C677T等5个相关基因和基因多态性的相关性研究[J].中国优生与遗传杂志,2013,21(12):26-29.
[11] 曹美群.冠心病伴抑郁发作及其血瘀证、痰浊证的相关基因多态性研究[D].长沙:中南大学,2007.
[12] 罗丹,鄢盛恺,李君亚,等.甲基四氢叶酸还原酶 C677T基因多态性与2型糖尿病合并冠心病的关系[J].临床检验杂志,2007,25(2):114-116.
[13] German CA,Shapiro MD. Polygenic Risk Scores to Identify CVD Risk and Tailor Therapy:Hope or Hype?[J]. Curr Atheroscler Rep,2021,23(9):47.
[14] Chen R,Morris BJ,Donlon TA,et al. FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease [J]. Aging(Albany NY),2020,12(23):23509-23524.
[15] Beghi S,Cavaliere F,Manfredini M,et al. Polymorphism rs7214723 in CAMKK1:a new genetic variant associated with cardiovascular diseases [J]. Biosci Rep,2021,41(7):BSR20210326.
[16] Zhao G,Yang W,Wu J,et al. Influence of a Coronary Artery Disease-Associated Genetic Variant on FURIN Expression and Effect of Furin on 17 [J]. Macrophage Behavior.Arterioscler Thromb Vasc Biol,2018,38(8):1837-1844.
[17] Vazdar L,Gabric ID,Kruljac I,et al. Influence of Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in early-stage HER2 positive breast cancer [J]. Sci Rep,2021,11(1):14395.
[18] Yuan W,Zhang W,Zhang W,et al. New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1(CDKN2B-AS1)rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease [J]. Bioengineered,2020,11(1):1084-1098.
[19] Park HS,Sung JH,Ryu CS,et al. The Synergistic Effect of Plasminogen Activator Inhibitor-1(PAI-1)Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population [J]. J Pers Med,2020,10(4):257.
[20] Hernandez V,Kaur K,ElSharief MW,et al. The New Kid on the Block:The Mechanisms of Action of Hyperleptinemia in Coronary Artery Disease and Atherosclerosis [J]. Cureus,2021,13(6):e15766.
[21] Rostami S,Hoff M,Dalen H,et al. Genetic risk score associations for myocardial infarction are comparable in persons with and without rheumatoid arthritis:the population-based HUNT study [J]. Sci Rep,2020,10(1):20416.
[22] Abdulfattah SY,Al-Awadi SJ. ApoB gene polymorphism(rs676210)and its pharmacogenetics impact on atorvastatin response among Iraqi population with coronary artery disease [J]. J Genet Eng Biotechnol,2021,19(1):95.
[23] Kucukhuseyin O,Kurnaz O,Akadam-Teker AB,et al. The association of MTHFR C677T gene variants and lipid profiles or body mass index in patients with diabetic and nondiabetic coronary heart disease [J]. J Clin Lab Anal,2013,27(6):427-434.
[24] Ramkaran P,Phulukdaree A,Khan S,et al. Methylenetetrahydrofolate reductase C677T polymorphism is associated with increased risk of coronary artery disease in young South African Indians [J]. Gene,2015,15(571):28-32. |
|
|
|